NPS Pharmaceuticals Submits Biologic License Application to the U.S. Food and Drug Administration for Natpara® in HypoparathyroidismBY Business Wire
— 2:23 PM ET 10/24/2013
It's the unknown positives that will propel NPSP considerable higher in the near future. Growing revenues and % of positive growth potential are still unknown. I see $50+ in the months ahead. I like our chances here.
Sentiment: Strong Buy
Lest we forget Fidelity still owns 25% of this stock and have a history of sticking around for a long time
decaf---------YES. 2012 q3 sensipar was about 243 million. 2013 q3 sensipar sales were 259+ million. About 6.5-7 % higher than last year. Gattex written rx, sales and profit may be substantially higher. Dr. Nader seemed to say EU sales may be more than sales un the USA. Add in Sesipar royalty, Natpara rollout next year, and other goodys and NPSP may goo to 100+ in 3-5 years. Sit tight.
Sentiment: Strong Buy
I agree - I believe we've had the pull-back that Cramer was looking for and we move back to the $33 to $35 range on positive earnings call.
Sales on 3q2013 were 183m in Us and 76m on rest of world (259m total)
Sales on 2q2013 were 178m in US and 81m on rest of world (259m total)
Sales on 3q2012 were 172m in US and 71m on rest of world (243m total)
So, basically sales were flat over 2Q13 and up 7% on 3q12
On 2q13 Npsp reported earning of 29m from sensipar royalties (but with a positive impact of 2M retrospective adjustment) and so the net was 27M.
With the numbers provided from Amgen sales royalties for NPSP will be around 26M (slightly lower respect of 2Q13)
Source: amgen web site, npsp web site
That is a big increase over last qtr. $184.1M to $259m. Unit sales must be through the roof. 319,000 to ??? Where is the source?
translation, kudos on two accounts your returns on NPSP and understanding the real value of this site. Poster's who think they influence price setting big boys are delusional. NPSP is in the grip of bears until we see several back to back bull days.
Exchanging opinions with thinking investors or traders, like you, is valuable. Ranting, or mouthing mindless expletives by fools is a dumb waste of time.